Cary Street Partners Investment Advisory LLC Fulgent Genetics, Inc. Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$28.52 - $40.7 $2,880 - $4,110	101 New	101 $3,000
Q4 2020 Feb 12, 2021	SELL	$31.01 - $52.1 $12,404 - $20,840	-400 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$15.89 - $50.51 $6,356 - $20,204	400 New	400 $16,000

Others Institutions Holding FLGT

# of Institutions

201

Shares Held

16.1M

Call Options Held

2.04M

Put Options Held

14K

Black Rock Inc. New York, NY

3.92M
Shares

$78.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.45M
Shares

$29.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.27M
Shares

$25.6 Million
0.01% of portfolio
Dimensional Fund Advisors LP Austin, TX

1.11M
Shares

$22.3 Million
0.01% of portfolio
State Street Corp Boston, MA

794K
Shares

$16 Million
0.0% of portfolio

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account